SCHEMBL3846341

SCHEMBL3846341

N#Cc1cccc(OC2CCN(c3ncnc4ccc(Br)cc34)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CLK4 Q9HAZ1 2/20 0.52
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 1/20 0.51
USP2 O75604 1/20 0.51
KMT2A Q03164 1/20 0.51
HIF1A Q16665 1/20 0.51
PDE3B Q13370 4/20 0.50
PDE3A Q14432 4/20 0.50
PDE10A Q9Y233 4/20 0.50
CHRM4 P08173 3/20 0.50
GPR6 P46095 2/20 0.49
DCK P27707 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PDGFRB P09619 1/20 0.45
LRRK2 Q5S007 1/20 0.43
HRH1 P35367 1/20 0.43
CCR3 P51677 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20302706 0.77 CHRM4 (0.55) PDE3BPDE3APDE10ACHRM4GPR6
SCHEMBL29596084 0.77 CHRM4 (0.55) PDE3BPDE3APDE10ACHRM4GPR6
SCHEMBL3849787 0.77 CHRM4 (0.58) HTTALDH1A1PDE3BPDE3APDE10A
SCHEMBL3845658 0.75 CHRM4 (0.56) HTTALDH1A1PDE3BPDE3APDE10A
SCHEMBL20298457 0.75 CHRM4 (0.53) PDE3BPDE3APDE10ACHRM4GPR6
SCHEMBL29596368 0.75 CHRM4 (0.53) PDE3BPDE3APDE10ACHRM4GPR6
SCHEMBL20298444 0.75 CHRM4 (0.53) PDE3BPDE3APDE10ACHRM4GPR6
SCHEMBL29595610 0.72 CHRM4 (0.50) CYP1A2CYP3A4CLK4ALDH1A1MEN1
SCHEMBL20298438 0.72 CHRM4 (0.50) CYP1A2CYP3A4CLK4ALDH1A1MEN1
SCHEMBL20303508 0.71 CHRM4 (0.63) CHRM4GPR6DCKLRRK2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed